If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Download FREE Excerpt
21 Info Graphics
1 Data Graphics
31 Best Practices
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Pharmaceutical; Research; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Professional Services; Health Care
AAI Corporation; Sanofi-aventis; America's Doctor; AstraZeneca; Bayer; BBK Healthcare; Bristol-Myers Squibb; Central Texas Clinical Research; Covance; East Bay Clinical Trial Center; Eli Lilly; Genesis Clinical Research Corporation; GlaxoSmithKline; Health Decisions; Nashville Clinical Research; Pfizer; PPD; Richard H. Weisler & Associates; Roche; Spartanburg Pharmaceutical; Virginia Commonwealth University; Wake Forest University
Competition within the pharmaceutical industry continues to intensify, and competing for clinical investigators and patients is no exception. While pharmaceutical companies invest heavily in marketing approved drugs, they often do not employ that same market research and marketing expertise when it comes to targeting, positioning and communicating the value of clinical trials to study sites and patients. The research data underscores the high stakes and urgent need for pharmaceutical companies to improve the clinical trial process. Effective communications can result in better-selected study sites and patients who will remain with a study until it is completed -- saving time and money in clinical trials.
This Best Practices Benchmarking® Report examines the best practices of a highly-regarded group of pharmaceutical companies and contract organizations, as well as insights from several study site coordinators. Best Practices, LLC researchers analyzed several critical issues, including using marketing techniques to profile patients and investigators for better site selection, developing effective positioning and training messages to recruit and prepare study sites, and supporting study sites in recruiting and retaining patients.
By studying other organization's best practices in communicating the value of clinical studies, your company can understand the techniques, methods and channels that lead to excellence in the area of clinical communications.
Clinical communications plays a significant role in the costs and timelines involved in developing a pharmaceutical product during a clinical trial. As such, clinical operations and development leaders seek to understand the key drivers affecting their ability to deliver targeted, effective communications through appropriate channels -- traditionally a marketing competence. Throughout research with the benchmark class, Best Practices, LLC analysts identified three critical success factors used by industry-leading pharmaceutical companies for communicating the value of studies to investigators and patients:
• Leveraging Marketing and Recruitment Expertise for Clinical Trials Planning
• Defining Site Selection Criteria
• Maximizing Diverse Sources to Identify Sites
• Using Marketing Expertise to Communicate with Study Sites
• Generating Study Interest
• Preparing Sites for Study Success
• Engaging and Enrolling Patients
• Supporting Retention Efforts
List of Charts & Exhibits
Integrate Science and Marketing to Recruit Sites Effectively
Using Knowledge Exchanges to Improve Future Studies
Develop a Partner Relationship to Share Expertise
Clinical Communications Cycle Starts with Patient Information
Site Selection Factors
Strategically Selecting Study Sites
Using Multiple Sources to Select Investigators
Example of Site Metrics
Site Communications Team Members
Emphasizing Appealing Study Aspects
Investigator Meeting Agenda
Communication to Drive Patient Recruitment and Retention
Address Patients’ Motivation Factors through Customized Messages
Trial Enrollment Incentives
Overcome Barriers Preventing Patient Participation
Incentives that Encourage Patients to Remain in Clinical Trials
Train for Process Improvements
Frequent and Effective Communications Drives Study Success
Motivate Sites through Continuous Communication